Role of individual amino acids of apolipoprotein A-I in the activation of lecithin:cholesterol acyltransferase and in HDL rearrangements
- PMID: 11254750
Role of individual amino acids of apolipoprotein A-I in the activation of lecithin:cholesterol acyltransferase and in HDL rearrangements
Abstract
The central region of apolipoprotein A-I (apoA-I), spanning residues 143--165, has been implicated in lecithin:cholesterol acyltransferase (LCAT) activation and also in high density lipoprotein (HDL) structural rearrangements. To examine the role of individual amino acids in these functions, we constructed, overexpressed, and purified two additional point mutants of apoA-I (P143R and R160L) and compared them with the previously studied V156E mutant. These mutants have been reported to occur naturally and to affect HDL cholesterol levels and cholesterol esterification in plasma. The P143R and R160L mutants were effectively expressed in Escherichia coli as fusion proteins and were isolated in at least 95% purity. In the lipid-free state, the mutants self-associated similarly to wild-type protein. All the mutants, including V156E, were able to lyse dimyristoylphosphatidylcholine liposomes. In the lipid-bound state, the major reconstituted HDL (rHDL) of the mutants had diameters similar to wild type (96--98 A). Circular dichroism and fluorescence methods revealed no major differences among the structures of the lipid-free or lipid-bound mutants and wild type. In contrast, the V156E mutant had exhibited significant structural, stability, and self-association differences compared with wild-type apoA-I in the lipid-free state, and formed rHDL particles with larger diameters. In this study, limited proteolytic digestion with chymotrypsin showed that the V156E mutant, in lipid-free form, has a distinct digestion pattern and surface exposure of the central region, compared with wild type and the other mutants. Reactivity of rHDL with LCAT was highest for wild type (100%), followed by P143R (39%) and R160L (0.6%). Tested for their ability to rearrange into 78-A particles, the rHDL of the two mutants (P143R and R160L) behaved normally, compared with the rHDL of V156E, which showed no rearrangement after the 24-h incubation with low density lipoprotein (LDL). Similarly, the rHDL of V156E was resistant to rearrangement in the presence of apoA-I or apoA-II. These results indicate that structural changes are absent or modest for the P143R and R160L mutants, especially in rHDL form; that these mutants have normal conformational adaptability; and that LCAT activation is obliterated for R160L.Thus, individual amino acid changes may have markedly different structural and functional consequences in the 143--165 region of apoA-I. The R160L mutation appears to have a direct effect in LCAT activation, while the P143R mutation results in only minor structural and functional effects. Also, the processes for LCAT activation and hinge mobility appear to be distinct even if the same region of apoA-I is involved. -- Cho, K-H., D. M. Durbin, and A. Jonas. Role of individual amino acids of apolipoprotein A-I in the activation of lecithin:cholesterol acyltransferase and in HDL rearrangements. J. Lipid Res. 2001. 42: 379--389.
Similar articles
-
A key point mutation (V156E) affects the structure and functions of human apolipoprotein A-I.J Biol Chem. 2000 Sep 1;275(35):26821-7. doi: 10.1074/jbc.M002841200. J Biol Chem. 2000. PMID: 10858436
-
Lipid-free apolipoproteins A-I and A-II promote remodeling of reconstituted high density lipoproteins and alter their reactivity with lecithin:cholesterol acyltransferase.J Lipid Res. 1999 Dec;40(12):2293-302. J Lipid Res. 1999. PMID: 10588955
-
The carboxyl-terminal hydrophobic residues of apolipoprotein A-I affect its rate of phospholipid binding and its association with high density lipoprotein.J Biol Chem. 1997 Jul 11;272(28):17511-22. doi: 10.1074/jbc.272.28.17511. J Biol Chem. 1997. PMID: 9211897
-
Apolipoprotein A-I: structure-function relationships.J Lipid Res. 2000 Jun;41(6):853-72. J Lipid Res. 2000. PMID: 10828078 Review.
-
The effects of altered apolipoprotein A-I structure on plasma HDL concentration.Trends Cardiovasc Med. 2002 Apr;12(3):121-8. doi: 10.1016/s1050-1738(01)00163-3. Trends Cardiovasc Med. 2002. PMID: 12007737 Review.
Cited by
-
Naturally occurring and bioengineered apoA-I mutations that inhibit the conversion of discoidal to spherical HDL: the abnormal HDL phenotypes can be corrected by treatment with LCAT.Biochem J. 2007 Aug 15;406(1):167-74. doi: 10.1042/BJ20070296. Biochem J. 2007. PMID: 17506726 Free PMC article.
-
A thumbwheel mechanism for APOA1 activation of LCAT activity in HDL.J Lipid Res. 2018 Jul;59(7):1244-1255. doi: 10.1194/jlr.M085332. Epub 2018 May 17. J Lipid Res. 2018. PMID: 29773713 Free PMC article.
-
Structure and stability of apolipoprotein a-I in solution and in discoidal high-density lipoprotein probed by double charge ablation and deletion mutation.Biochemistry. 2006 Jan 31;45(4):1242-54. doi: 10.1021/bi051669r. Biochemistry. 2006. PMID: 16430220 Free PMC article.
-
The interplay between size, morphology, stability, and functionality of high-density lipoprotein subclasses.Biochemistry. 2008 Apr 22;47(16):4770-9. doi: 10.1021/bi7023354. Epub 2008 Mar 27. Biochemistry. 2008. PMID: 18366184 Free PMC article.
-
Sequence-specific apolipoprotein A-I effects on lecithin:cholesterol acyltransferase activity.Mol Cell Biochem. 2013 Jun;378(1-2):283-90. doi: 10.1007/s11010-013-1619-5. Epub 2013 Mar 21. Mol Cell Biochem. 2013. PMID: 23516040
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous